{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:00:06Z","timestamp":1790830806839,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,9,28]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>SLC7A11 is part of the solute carrier family and encodes the\ntransporter xCT. However, its functional role in renal cell carcinoma (RCC) progression\nand associated tumor microenvironment (TME) modulation remains poorly characterized\nand requires further investigation. This study aimed to explore SLC7A11 expression\npatterns and their prognostic value, focusing on changes in TME and immune cell infiltration\ndynamics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Multi-omics data from TCGA, GTEx, and four GEO cohorts were analyzed,\nfollowed by immunohistochemical validation on 498 clinical renal specimens. Bioinformatic\ntools, including co-expression networks, GSEA, ESTIMATE, CIBERSORT,\nTIMER2.0, and Kaplan-Meier survival analysis, were applied to dissect signaling pathways\nand immune infiltration. SiRNA-mediated SLC7A11 knockdown in 786-O and OSRC2\ncell lines was conducted to detect cell proliferation, migration, invasion, and cell\ncycle changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>SLC7A11 was significantly upregulated in KIRC, KIRP and KICH compared\nwith normal renal tissues (P&lt;0.05). SLC7A11-related genes were enriched in cell cycle,\nDNA replication, p53, ferroptosis, and IL-17 pathways. High SLC7A11 correlated with\nelevated tumor-associated macrophages and reduced CD8+ T cells, predicting poor overall\nsurvival. Knocking down SLC7A11 suppressed malignant phenotypes of RCC cells,\ninduced G0\/G1 arrest, and downregulated Cyclin D1\/Cyclin B1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>SLC7A11 exerted oncogenic effects across all primary RCC subtypes. SLC7A11\nremodeled the TME by recruiting and polarizing tumor-associated macrophages.\nMechanistically, it promoted RCC progression by activating cell cycle pathways to sustain\nunrestrained cell proliferation. The crosstalk among SLC7A11, ferroptosis, and immune\nsignaling provides new evidence for combining ferroptosis induction with immunotherapy\nin RCC treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>SLC7A11 was an adverse prognostic biomarker overexpressed in all main\nRCC subtypes. It remodeled the TME by weakening the immune response via\nmacrophages and disrupting normal cell growth regulation. Targeting SLC7A11 was a\npromising combinatorial therapeutic strategy for RCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673487882260908065601","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:44:21Z","timestamp":1790829861000},"source":"Crossref","is-referenced-by-count":0,"title":["SLC7A11 as a Prognostic Biomarker and Therapeutic Target in Renal\nCell Carcinoma: Insights into Tumor Microenvironment Remodeling\nand Immune Infiltration"],"prefix":"10.2174","volume":"33","author":[{"given":"Xinyang","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixin","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingze","family":"Xu","sequence":"additional","affiliation":[{"name":"Departmentof Pathology, The Fourth Affiliated Hospital of Soochow University, Suzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Gan","sequence":"additional","affiliation":[{"name":"Departmentof Pathology, The Fourth Affiliated Hospital of Soochow University, Suzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifei","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673487882260908065601","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258852\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673487882260908065601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:45:21Z","timestamp":1790829921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258852\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673487882260908065601","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}